Breaking News

Big Tech companies are harming – not helping – healthcare

Not rendering correctly? View this email as a web page here.

StartUPDATES: New developments from healthcare startups

By Stephanie Baum Friday, March 4, 2022 7:15 AM

Read about news from Equiva, Doceree, Verana Health and XR Health.

Read more »

Cancer biotech Rondo gets $67M to step on the gas with next-gen bispecific drugs

By Frank Vinluan Thursday, March 3, 2022 8:00 PM

Rondo Therapeutics is developing bispecific antibody drugs capable of treating solid tumors, which have eluded this type of cancer therapy. Led by co-founders and Teneobio veterans Shelley Force Aldred and Nathan Trinklein, the biotech startup has emerged from stealth backed by a $67 million Series A round of funding.

Read more »

AI attempts to tackle radiology provider shortage, while also improving outcomes

By Emma Bardin Thursday, March 3, 2022 6:44 PM

Several AI solutions for various indications in radiology – from x-rays to CT scans to ultrasounds – aim to address not only the radiologist provider shortage, but also improve the current standard of care, whether shortening times or increasing accuracy.

Read more »

Sutter Health chief of digital health shares digital health integration insights [Sponsored]

By Stephanie Baum Thursday, March 3, 2022 4:43 PM

Sutter Health Chief of Digital Health Dr Albert Chan is taking part in a panel discussion about the patient experience at the ViVE conference by HLTH and CHIME in Miami Beach March 6-9. In an interview, he discussed some of the digital health tools they've implemented from behavioral health to maternity care and AI.

Read more »

CancerIQ raises $14M to grow its platform focused on early detection and prevention

By Michael Schroeder Thursday, March 3, 2022 4:38 PM

The Series B financing round was co-led by Merck Global Health Innovation Fund and Amgen Ventures. The company's Black female co-founders have prioritized overcoming systemic barriers to cancer prevention that have led to higher death rates for minorities.

Read more »

Nonprofit drugmaker Civica Rx unveils plans for insulin biosimilars, $30 per vial

By Frank Vinluan Thursday, March 3, 2022 12:52 PM

Civica Rx plans to make lower cost versions of three branded insulin products, biosimilars that are expected to reach the market in 2024. In addition to $30 vials, Civica plans to sell pen cartridges at $55 for a box of five.

Read more »

Streamlining vaccine supply chains – it's all about the label

By Laura Johnson Thursday, March 3, 2022 10:00 AM

While a great deal of attention has been given to streamlining supply chains – and ensuring vaccines reach healthcare providers and their patients around the world – one of the most critical components is also the most overlooked: the label.

Read more »

   

No comments